Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $12 Million - $17 Million
-46,901 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $386,166 - $493,099
-1,099 Reduced 2.29%
46,901 $17.7 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $17.9 Million - $22 Million
48,000 New
48,000 $19.8 Million
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $491,568 - $634,060
-2,800 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$118.84 - $189.72 $332,752 - $531,216
2,800 New
2,800 $488,000
Q4 2019

Feb 13, 2020

SELL
$126.05 - $152.76 $617,645 - $748,524
-4,900 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $21.2 Million - $24.4 Million
-169,559 Reduced 97.19%
4,900 $649,000
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1.03 Million - $1.24 Million
8,325 Added 5.01%
174,459 $24.8 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $11 Million - $15.4 Million
104,834 Added 171.02%
166,134 $24.1 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $6.44 Million - $8.41 Million
61,300 New
61,300 $6.94 Million
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $11.2 Million - $13.4 Million
-99,847 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $9.54 Million - $10.9 Million
-93,167 Reduced 48.27%
99,847 $11.2 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $22.7 Million - $26.7 Million
-231,466 Reduced 54.53%
193,014 $20.6 Million
Q4 2017

Feb 09, 2018

BUY
$100.43 - $118.09 $25.4 Million - $29.9 Million
253,180 Added 147.8%
424,480 $46.5 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $16.6 Million - $18.7 Million
171,300
171,300 $18.5 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.